The authors have developed a GPT-based pharmacophore-informed generative model, TransPharmer, for bioactive small molecule design. Their methods have been successfully validated by designing potent and selective kinase inhibitors with chemical scaffolds different from previous ones.
- Weixin Xie
- Jianhang Zhang
- Jianfeng Pei
